51747
(4R)-Boc-4-苄基-Pyr-OBzl
≥96.0% (HPLC)
别名:
(2S,4R)-1-Boc-4-苄基-5-氧代吡咯烷-2-羧酸苄酯, (4R)-Boc-4-苄基-L-焦谷氨酸苄酯
方案
≥96.0% (HPLC)
反应适用性
reaction type: Boc solid-phase peptide synthesis
应用
peptide synthesis
SMILES字符串
CC(C)(C)OC(=O)N1[C@@H](C[C@@H](Cc2ccccc2)C1=O)C(=O)OCc3ccccc3
InChI
1S/C24H27NO5/c1-24(2,3)30-23(28)25-20(22(27)29-16-18-12-8-5-9-13-18)15-19(21(25)26)14-17-10-6-4-7-11-17/h4-13,19-20H,14-16H2,1-3H3/t19-,20+/m1/s1
InChI key
LMILJTUPJYRGKN-UXHICEINSA-N
其他说明
合成丝氨酸蛋白酶抑制剂
储存分类代码
13 - Non Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
M Llinàs-Brunet et al.
Bioorganic & medicinal chemistry letters, 10(20), 2267-2270 (2000-10-31)
Structure-activity studies on a hexapeptide N-terminal cleavage product of a dodecamer substrate led to the identification of very potent and highly specific inhibitors of the HCV NS3 protease/NS4A cofactor peptide complex. The largest increase in potency was accomplished by the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持